<?xml version="1.0" encoding="UTF-8"?>
<ref id="B2-medicina-57-00169">
 <label>2.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ansari</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Almatroudi</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Alzohairy</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>AlYahya</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Alomary</surname>
    <given-names>M.N.</given-names>
   </name>
   <name>
    <surname>Al-Dossary</surname>
    <given-names>H.A.</given-names>
   </name>
   <name>
    <surname>Alghamdi</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Lipid-based nano delivery of Tat-peptide conjugated drug or vaccineâ€“promising therapeutic strategy for SARS-CoV-2 treatment</article-title>
  <source>Expert Opin. Drug Deliv.</source>
  <year>2020</year>
  <volume>17</volume>
  <fpage>1671</fpage>
  <lpage>1674</lpage>
  <pub-id pub-id-type="doi">10.1080/17425247.2020.1813712</pub-id>
  <pub-id pub-id-type="pmid">32820694</pub-id>
 </element-citation>
</ref>
